A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease

[1] Ludwig J(1980)Nonalcoholic steatohepatitis Mayo Clinic Proc 55 434-438

[2] Viggiano TR(2000)Prevalance of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 112-117

[3] McGill DB(2004)Non-alcoholic steatohepatitis in the Asia- Pacific region: future shock? J Gastroenterol Hepatol 19 368-374

[4] Oh BJ(2005)The metabolic syndrome as a predictor of non-alcoholic fatty liver disease Ann Intern Med 143 722-778

[5] Bellentani S(1987)Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 524-526

[6] Saccoccio G(2005)Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313-1321

[7] Masutti F(2007)Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study Circulation 116 1367-1373

[8] Crocè LS(1997)Elevated circulating free fatty acid levels impair endothelium dependent vasodilatation J Clin Invest 100 1230-1239

[9] Brandi G(1999)Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467-2474

[10] Sasso F(2001)Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2486-2497

[1] Ludwig J(1980)Nonalcoholic steatohepatitis Mayo Clinic Proc 55 434-438

[2] Viggiano TR(2000)Prevalance of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 112-117

[3] McGill DB(2004)Non-alcoholic steatohepatitis in the Asia- Pacific region: future shock? J Gastroenterol Hepatol 19 368-374

[4] Oh BJ(2005)The metabolic syndrome as a predictor of non-alcoholic fatty liver disease Ann Intern Med 143 722-778

[5] Bellentani S(1987)Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 524-526

[6] Saccoccio G(2005)Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313-1321

[7] Masutti F(2007)Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study Circulation 116 1367-1373

[8] Crocè LS(1997)Elevated circulating free fatty acid levels impair endothelium dependent vasodilatation J Clin Invest 100 1230-1239

[9] Brandi G(1999)Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467-2474

[10] Sasso F(2001)Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2486-2497